Literature DB >> 20803178

Pediatric vasculitides: a generalists approach.

Raju P Khubchandani1, V Viswanathan.   

Abstract

Vasculitis is defined as the presence of inflammation in a blood vessel that may occur as a primary process or secondary to an underlying disease. Primary vasculitides are rare in children. These are defined by both the size of vessels involved and the type of inflammatory response. Clinical features consist of multi-organ involvement on a background of constitutional features reflecting the size and location of the blood vessels involved. Whilst some vasculitides are best diagnosed clinically, many forms require sophisticated imaging and other investigations (auto antibodies) to reveal the correct diagnosis. Prompt recognition and treatment is crucial as many of the vasculitides cause significant morbidity or mortality. Treatment options range from symptomatic therapy, immunosuppresive agents, intravenous immunoglobulin (IVIG) or biologic agents and are determined by the type of vasculitis, the severity of the inflammation, and the organ systems affected. Early detection and aggressive treatment is crucial for the best outcomes in the most severe forms of childhood vasculitis.

Entities:  

Mesh:

Year:  2010        PMID: 20803178     DOI: 10.1007/s12098-010-0132-z

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  10 in total

Review 1.  The many faces of cutaneous vasculitis.

Authors:  G Hautmann; G Campanile; T M Lotti
Journal:  Clin Dermatol       Date:  1999 Sep-Oct       Impact factor: 3.541

Review 2.  Vasculitis-aims of therapy. An overview.

Authors:  R A Watts; D G Scott; C D Pusey; C M Lockwood
Journal:  Rheumatology (Oxford)       Date:  2000-03       Impact factor: 7.580

3.  A new international classification of childhood vasculitis.

Authors:  Michael J Dillon; Seza Ozen
Journal:  Pediatr Nephrol       Date:  2006-07-04       Impact factor: 3.714

4.  Molecular imaging of Takayasu's arteritis and other large-vessel vasculitis with 18F-FDG PET.

Authors:  Myles Webb; Adil Al-Nahhas
Journal:  Nucl Med Commun       Date:  2006-07       Impact factor: 1.690

5.  Renal angiography in children with polyarteritis nodosa.

Authors:  Paul A Brogan; Roger Davies; Isky Gordon; Michael J Dillon
Journal:  Pediatr Nephrol       Date:  2002-04       Impact factor: 3.714

6.  Coronary magnetic resonance angiography in adolescents and young adults with kawasaki disease.

Authors:  Gerald F Greil; Matthias Stuber; René M Botnar; Kraig V Kissinger; Tal Geva; Jane W Newburger; Warren J Manning; Andrew J Powell
Journal:  Circulation       Date:  2002-02-26       Impact factor: 29.690

7.  The role of B-mode ultrasonography and electron beam computed tomography in evaluation of Takayasu's arteritis: a study of 43 patients.

Authors:  C Lefebvre; A Rance; J F Paul; C Beguin; O Bletry; Z Amoura; J C Piette; J N Fiessinger
Journal:  Semin Arthritis Rheum       Date:  2000-08       Impact factor: 5.532

Review 8.  Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review.

Authors:  H Narchi
Journal:  Arch Dis Child       Date:  2005-05-04       Impact factor: 3.791

9.  Juvenile polyarteritis: results of a multicenter survey of 110 children.

Authors:  Seza Ozen; Jordi Anton; Nil Arisoy; Aysin Bakkaloglu; Nesrin Besbas; Paul Brogan; Julia García-Consuegra; Pavla Dolezalova; Frank Dressler; Ali Duzova; Virgínia Paes Leme Ferriani; Maria Odete Esteves Hilário; Mercedes Ibáñez-Rubio; Ozgur Kasapcopur; Wietse Kuis; Thomas J A Lehman; Dana Nemcova; Susan Nielsen; Sheila Knupp Oliveira; Kenneth Schikler; Flavio Sztajnbok; Maria Teresa Terreri; Francesco Zulian; Patricia Woo
Journal:  J Pediatr       Date:  2004-10       Impact factor: 4.406

10.  Carotid and femoral artery stiffness in Takayasu's arteritis. An ultrasound study.

Authors:  Reino O Raninen; Markku M Kupari; Pauli E Hekali
Journal:  Scand J Rheumatol       Date:  2002       Impact factor: 3.641

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.